behavior/neurological
|
• water intake and urine output are increased at week 9 compared to single Lepr mutants
|
|
• food intake is increased over single Gdf15 mutants but is similar to single Lepr mutants
|
cardiovascular system
|
• increase in heart weight compared to controls, including that in single Lepr mutants
|
growth/size/body
|
• increase in heart weight compared to controls, including that in single Lepr mutants
|
|
• body weight is increased over nondiabetic single Gdf15 mutants but is similar to single Lepr mutants
|
|
• kidney weight is increased to a similar extent as in single Lepr mutants
|
|
• liver weight is increased to a similar extent as in single Lepr mutants
|
homeostasis/metabolism
|
• increase in serum creatinine levels compared to controls, including that in single Lepr mutants
|
|
• nonfasting blood glucose and HbA1c are higher in double mutants than in single Lepr mutants at the final time point of 18 weeks but are similar at earlier time points but higher than in single Gdf15 mutants
|
|
• urinary glucose loss is higher than in single Lepr mutants at week 14
|
|
• similar increase in cholesterol level as in single Lepr mutants
|
|
• similar increase in HDL levels as in single Lepr mutants
|
albuminuria
(
J:202996
)
|
• similar increase in urinary albumin excretion as in single Lepr mutants
|
liver/biliary system
|
• liver weight is increased to a similar extent as in single Lepr mutants
|
renal/urinary system
|
• urinary glucose loss is higher than in single Lepr mutants at week 14
|
albuminuria
(
J:202996
)
|
• similar increase in urinary albumin excretion as in single Lepr mutants
|
|
• marker analysis indicates that double mutants show an increase in renal damage and in interstitial and tubular damage in the kidney compared to single Lepr mutants
|
|
• kidney weight is increased to a similar extent as in single Lepr mutants
|
|
• glomerulosclerosis is similar as in single Lepr mutants
|
|
• water intake and urine output are increased at week 9 compared to single Lepr mutants
|